Table 3.
Comparison of balance and load distribution with eyes closed at baseline and after therapy.
| Outcome measure | Experimental Group | pa | ESa | Control Group | pa | ESa | pb | ESb | |
|---|---|---|---|---|---|---|---|---|---|
| COP path length (mm) | Baseline | 847 ± 554 | n.s. | 0.04 | 774 ± 491 | n.s. | 0.38 | n.s. | |
| Post | 837 ± 619 | 938 ± 359 | n.s. | 0.19 | |||||
| COP average velocity (mm/s) | Baseline | 28 ± 16 | n.s. | 0.05 | 26 ± 16 | n.s. | 0.35 | n.s. | |
| Post | 29 ± 19 | 31 ± 12 | n.s. | 0.12 | |||||
| Length of minor axis (mm) | Baseline | 32 ± 17 | n.s. | 0.37 | 24 ± 19 | n.s. | 0.12 | n.s. | |
| Post | 26 ± 15 | 22 ± 13 | n.s. | 0.28 | |||||
| Length of major axis (mm) | Baseline | 68 ± 44 | n.s. | 0.65 | 47 ± 45 | n.s. | 0.32 | n.s. | |
| Post | 46 ± 18 | 36 ± 15 | n.s. | 0.60 | |||||
| Angle to major axis (degree) | Baseline | 53 ± 26 | n.s. | 0.33 | 45 ± 28 | n.s. | 0.43 | n.s. | |
| Post | 44 ± 28 | 34 ± 22 | n.s. | 0.39 | |||||
| Deviation X (mm) | Baseline | 38 ± 32 | n.s. | 0.09 | 31 ± 23 | n.s. | 0.17 | n.s. | |
| Post | 35 ± 33 | 36 ± 34 | n.s. | 0.02 | |||||
| Deviation Y (mm) | Baseline | 46 ± 31 | n.s. | 0.27 | 25 ± 10 | 0.01 | 0.86 | n.s. | |
| Post | 38 ± 27 | 14 ± 15 | 0.03 | 1.09 | |||||
| Forefoot load involved (%) | Baseline | 53 ± 29 | n.s. | 0.08 | 53 ± 21 | n.s. | 0.46 | n.s. | |
| Post | 51 ± 19 | 63 ± 22 | n.s. | 0.58 | |||||
| Forefoot load uninvolved (%) | Baseline | 28 ± 23 | n.s. | 0.04 | 35 ± 10 | n.s. | 0.52 | n.s. | |
| Post | 27 ± 18 | 40 ± 9 | 0.04 | 0.91 | |||||
| Backfoot load involved (%) | Baseline | 46 ± 29 | n.s. | 0.08 | 46 ± 21 | n.s. | 0.46 | n.s. | |
| Post | 48 ± 19 | 36 ± 22 | n.s. | 0.58 | |||||
| Backfoot load uninvolved (%) | Baseline | 71 ± 23 | n.s. | 0.04 | 64 ± 10 | n.s. | 0.52 | n.s. | |
| Post | 72 ± 18 | 59 ± 9 | 0.04 | 0.91 | |||||
| Total load involved (%) | Baseline | 36 ± 21 | n.s. | 0.09 | 33 ± 14 | n.s. | 0.42 | n.s. | |
| Post | 38 ± 19 | 39 ± 14 | n.s. | 0.05 | |||||
| Total load uninvolved (%) | Baseline | 63 ± 21 | n.s. | 0.09 | 66 ± 14 | n.s. | 0.42 | n.s. | |
| Post | 61 ± 19 | 60 ± 14 | n.s. | 0.05 |
pa–p-value between baseline and post-therapy within each group.
pb–p-value between study groups.
ESa–effect size (Cohen d) within each group.
ESb–effect size (Cohen d) between study groups.
COP—center of pressure.
n.s.—non-significant.
Values are expressed as mean ± SD.
Statistically significant results are marked in bold.